Management of Inflammatory Bowel Disease in Patients with Current or Past Malignancy

SIMPLE SUMMARY: Physicians face therapeutic choices in an increasing number of IBD patients with current or past malignancy. Even if uncontrolled IBD may lead to severe complications, promoting cancer relapse through the use of immunomodulators is a concern. There is a lack of scientific evidence su...

Descripción completa

Detalles Bibliográficos
Autores principales: Poullenot, Florian, Laharie, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954488/
https://www.ncbi.nlm.nih.gov/pubmed/36831424
http://dx.doi.org/10.3390/cancers15041083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954488/
https://www.ncbi.nlm.nih.gov/pubmed/36831424
http://dx.doi.org/10.3390/cancers15041083

Ejemplares similares